Beam Therapeutics (BEAM) Tax Provisions (2022 - 2025)

Beam Therapeutics (BEAM) has reported Tax Provisions for 4 consecutive years, with -$16.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Tax Provisions changed N/A year-over-year to -$16.8 million; the TTM figure through Dec 2025 stood at -$16.8 million (down 43174.36% YoY), while the FY2025 annual figure was -$16.8 million, down 43174.36% from the prior year.
• Tax Provisions retreated to -$16.8 million in Q4 2025 per BEAM's latest filing, from $39000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $2.4 million in Q3 2022 and bottomed at -$16.8 million in Q4 2025.
• Historically, Tax Provisions has averaged -$2.4 million across 4 years, with a median of $1.0 million in 2022.
• On a YoY basis, Tax Provisions climbed as much as 40.0% in 2023 and fell as far as 40.0% in 2023.
• Beam Therapeutics' Tax Provisions stood at $1.0 million in 2022, then jumped by 40.0% to $1.4 million in 2023, then tumbled by 97.21% to $39000.0 in 2024, then slumped by 43174.36% to -$16.8 million in 2025.
• Business Quant data shows BEAM's Tax Provisions at -$16.8 million in Q4 2025, $39000.0 in Q2 2024, and $1.4 million in Q4 2023.